We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Faeth Therapeutics Stock

Invest in or calculate the value of your shares in Faeth Therapeutics or other pre-IPO companies through EquityZen's platform.

Get Started

Faeth Therapeutics Stock (FATH)

Faeth Therapeutics is a cancer metabolism company that focuses on nutrition treatments for cancer patients.

About Faeth Therapeutics Stock

Founded

2019

Headquarters

San Francisco, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Faeth Therapeutics is a data-driven, evidence-based company that specializes in mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. It fully focuses on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy. The company was founded to translate breakthrough discoveries, made by cancer research laboratories, into clinical practice. Its founding team includes some of the industry’s preeminent researchers and clinicians.

Faeth Therapeutics Management

Leadership team at Faeth Therapeutics

Founder & CEO

Anand Parikh

Chief Medical Officer

Thomas Strack

Locked Features

Join now and verify your accreditation status to gain access to:

  • Faeth Therapeutics current valuation
  • Faeth Therapeutics stock price
  • Available deals in Faeth Therapeutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Faeth Therapeutics stock?

Accredited investors can buy pre-IPO stock in companies like Faeth Therapeutics through EquityZen funds. These investments are made available by existing Faeth Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Faeth Therapeutics stock?

Shareholders can sell their Faeth Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."